Number of the records: 1
COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes
SYS 0558632 005 20230418204905.7 014 $a 85132081170 $2 SCOPUS 014 $a 35711466 $2 PUBMED 014 $a 000811304700001 $2 WOS 017 70
$a 10.3389/fimmu.2022.890517 $2 DOI 101 0-
$a eng $d eng 102 $a CH 200 1-
$a COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes 215 $a 16 s. $c P 463 -1
$1 001 cav_un_epca*0378913 $1 011 $a 1664-3224 $e 1664-3224 $1 200 1 $a Frontiers in Immunology $v Roč. 13, MAY (2022) $1 210 $c Frontiers Media 608 $a Review 610 $a insulin-resistance 610 $a sex-differences 610 $a adipose-tissue 610 $a cytokine storm 610 $a liver-disease 610 $a alcohol-use 610 $a coronavirus 610 $a infections 610 $a obesity 610 $a mechanisms 610 $a coronavirus disease 2019 610 $a covid-19 610 $a immune responses 610 $a cancer 610 $a cardiovascular disease 610 $a diabetes 610 $a treatment implications 700 -1
$3 cav_un_auth*0443472 $a Bigdelou $b B. $y US $4 070 701 -1
$3 cav_un_auth*0443473 $a Sepand $b M. $y US $4 070 701 -1
$3 cav_un_auth*0443474 $a Najafikhoshnoo $b S. $y US $4 070 701 -1
$3 cav_un_auth*0443475 $a Negrete $b J. $y US $4 070 701 -1
$3 cav_un_auth*0336248 $a Sharaf $b M. $y SA 701 -1
$3 cav_un_auth*0443476 $a Ho $b J. $y US $4 070 701 -1
$3 cav_un_auth*0443477 $a Sullivan $b I. $y US $4 070 701 -1
$3 cav_un_auth*0443471 $a Chauhan $b Prashant $p BC-A $i PAU - Molekulární parazitologie $j Molecular Parasitology $y IN $T Biologické centrum AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0443478 $a Etter $b M. $y CH $4 070 701 -1
$3 cav_un_auth*0443479 $a Shekarian $b T. $y CH $4 070 701 -1
$3 cav_un_auth*0443480 $a Liang $b O. $y US $4 070 701 -1
$3 cav_un_auth*0443481 $a Hutter $b G. $y CH $4 070 701 -1
$3 cav_un_auth*0443482 $a Esfandiarpour $b R. $y US $4 070 $z K 701 -1
$3 cav_un_auth*0443483 $a Zanganeh $b S. $y US $4 070 $z K 856 $u https://www.frontiersin.org/articles/10.3389/fimmu.2022.890517/full $9 RIV
Number of the records: 1